Ironwood and CSO sued by Synergy over guanylate cyclase receptor agonists

Ironwood Pharmaceuticals, a Cambridge, Massachusetts biotechnology firm, is facing a lawsuit seeking $500 million in damages by Synergy Pharmaceuticals, a New York-based firm. Both firms are developing drugs in the gastro-intestinal area.

Ironwood Pharmaceuticals, a Cambridge, Massachusetts biotechnology firm, is facing a lawsuit seeking $500 million in damages by Synergy Pharmaceuticals, a New York-based firm. Both firms are developing drugs in the gastro-intestinal area.

Synergy said in a statement that it filed a lawsuit in New York State Supreme Court against Ironwood and its...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category